Press release

Savara to Participate in Two Upcoming Investor Healthcare Conferences

Piper Sandler 33rd Annual Virtual Healthcare Conference Evercore ISI 4th Annual HealthCONx Virtual Conference AUSTIN, Texas--(BUSINESS WIRE)-- Savara Inc.

articleSavara, Inc.November 15, 20215/company/savara-inc/news/savara-to-participate-in-two-upcoming-investor-healthcare-conferences-2021-11-15
Savara to Participate in Two Upcoming Investor Healthcare Conferences

About this update from Savara, Inc.

[{"type":"text","content":"\nPiper Sandler 33rd Annual Virtual Healthcare Conference\n\nEvercore ISI 4th Annual HealthCONx Virtual Conference\n\n AUSTIN, Texas--(BUSINESS WIRE)--\nSavara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences:\n\n\nPiper Sandler 33rd Annual Virtual Healthcare Conference: A pre-recorded webcast of the presentation will be available beginning at 10:00 AM ET / 7:00 AM PT on November 22, 2021.\n\n\n\nEvercore ISI 4th Annual HealthCONx Virtual Conference: A live webcast of a fireside chat will take place at 8:50 AM ET / 5:50 AM PT on November 30, 2021.\n\n\nBoth webcasts will be available through the Investors page of Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.\n\nAbout Savara\n\nSavara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211115005335/en/\n\nSavara Inc. IR & PR\nAnne Erickson\nSenior Vice President, Chief of Staff\[email protected]\n(512) 851-1366\n\nSource: Savara Inc.","length":4803,"tagName":"div"}]

More updates from Savara, Inc.